Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes
Eating disorders
By donating acetyl groups to NF-B p65/RelA, ALC enhances transcription of the GRM2 gene encoding metabotropic glutamate 2 (mGlu2) receptors.[11][12] This upregulation of mGlu2 receptors at nerve terminals produces analgesia and prevents spinal sensitization, with effects that persist for weeks to months after discontinuationa feature distinguishing ALC from conventional analgesics.[11] In experimental models, ALC blocks wind-up and long-term potentiation in dorsal horn neurons, key processes underlying central sensitization.[11] The analgesic effects of ALC outlast the end of treatment in mouse models of chronic inflammatory and neuropathic pain, with effects persisting 37 days after drug withdrawal compared to 7-15 days for pregabalin or amitriptyline.[11] Clinical evidence in fibromyalgia (a prototypical central sensitization condition) supports this mechanism, with multiple RCTs demonstrating benefit.[11] Combination Strategies for Central Sensitization: ALC 1,500-2,000 mg/day + PEA 1,200 mg/day (demonstrated synergy in fibromyalgia)[3] + Magnesium 400-600 mg/day (complementary glutamate modulation) + Low-dose naltrexone (complementary anti-sensitization mechanisms) 2
A pivotal study that showed that in rodents, glucose shortage and sleep deprivation increase susceptibility to cortical spreading depression and open pannexin-1 megachannels, enabling activation of the trigeminovascular system
Pediatr Res 18:13251328
General treatment After treating nutrition impact symptoms and reversible underlying metabolic derangement, cancer patients with persistent symptoms of anorexia and weight loss should be assessed and treated sooner rather than later during the trajectory of weight loss
